Zeta Surgical has announced the close of US$5.2 million in seed financing—and will use these funds to finalise development of its neurosurgical navigation platform, Zeta, and its non-invasive focused ultrasound system, ZetaFUS.
The completion of initial clinical studies, obtaining US Food and Drug Administration (FDA) clearance, and expanding its growing technical and clinical teams, are also among the company’s goals following this funding round, which was led by Innospark Ventures with participation from TSVC, Y Combinator, Trevor Fetter and others.
“TSVC is very excited to partner with Zeta Surgical to bring AI [artificial intelligence] to precision surgical navigation, to make neurosurgery lower cost and more accessible,” said Eugene Zhang, founding partner of TSVC.
“To date, the use of surgical guidance has been limited to long, operating room-based interventions, due to its invasiveness and complex deployment,” added Jose Amich, co-founder and CEO of Zeta. “Our goal is to provide physicians with a robust, fast and accurate guidance system deployable during any case, irrespective of where they are in the hospital or what hospital they are in. We are thrilled to be partnering with such a strong group of investors who are aligned with our mission to improve access to safe and effective surgery.”